Loading...

Psyence Group Inc.

PSYGFPNK
Healthcare
Drug Manufacturers - General
$0.12
$0.00(0.00%)

Psyence Group Inc. (PSYGF) Company Profile & Overview

Explore Psyence Group Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Psyence Group Inc. (PSYGF) Company Profile & Overview

Psyence Group Inc., a life science biotechnology company, engages in the commercial psilocybin mushroom cultivation and production activities. Its natural psilocybin is used for the treatment of a range of mental health disorders and other medical conditions. The company is developing pharmaceutical preparations of psilocybin doses to help heal psychological trauma and diagnosable disorders, including anxiety, depression, post-traumatic stress disorder, and grief and bereavement. It also focuses on the development, distribution, and sale of over-the-counter non psilocybin containing functional mushroom nutraceutical products under the GOODMIND brand. Psyence Group Inc. was founded in 2019 and is based in Toronto, Canada.

SectorHealthcare
IndustryDrug Manufacturers - General
CEOJody Aufrichtig

Contact Information

200 Bay Street, Toronto, ON, M5J 2J1

Company Facts

IPO DateMay 31, 2022
CountryCA

Frequently Asked Questions

;